Journal ArticleOPEN ACCESS

Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir

  • Patil R
  • Ona M
  • Papafragkakis H
  • et al.
Case Reports in Hepatology (2015) 2015 1-2
DOI: 10.1155/2015/280353
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The fixed-dose combination of Efavirenz/Emtricitabine/Tenofovir is a first-line agent for the treatment of HIV; however few cases have reported hepatotoxicity associated with the drug. We report a case of Efavirenz/Emtricitabine/Tenofovir-associated hepatotoxicity presenting mainly with hepatocellular injury characterized by extremely elevated aminotransferase levels, which resolved without acute liver failure or need for liver transplant referral.

Cite

CITATION STYLE

APA

Patil, R., Ona, M. A., Papafragkakis, H., Carey, J., Moshenyat, Y., Alhaddad, A., & Anand, S. (2015). Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir. Case Reports in Hepatology, 2015, 1–2. https://doi.org/10.1155/2015/280353

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free